Virus News and Research

Latest Virus News and Research

All health care workers should be vaccinated with annual flu vaccine to protect patients

All health care workers in health care institutions should be vaccinated with the annual influenza vaccine to protect patients, argues an editorial in CMAJ (Canadian Medical Association Journal).

30 Oct 2012

RUB-medical researchers receive $2.3M Gates Foundation grant for HIV vaccine research

To support their research for a vaccine against the HI-Virus, Prof. Dr. Klaus Überla of the Faculty for Medicine at the Ruhr-Universität Bochum and his research team will receive $2.3 million in funding within the next three years from the Bill & Melinda Gates Foundation. The scientists are part of the Collaboration for AIDS Vaccine Discovery (CAVD), which seeks to speed up the development of an HIV-vaccine through a rigorous exchange of information, methods and reagents.

29 Oct 2012

New HIV test for babies differs from conventional test, delivers diagnosis in less than an hour

Today, mothers in Africa sometimes walk more than 10 miles to a clinic only to learn that conventional HIV test results for their babies are not available yet.

29 Oct 2012

UNICEF calls for 'finishing' global polio eradication; Rotary International warns of funding shortfall in India

UNICEF on Wednesday "called for continued dedication in 'finishing the job' in eradicating polio, while also applauding India for being 'declared polio free' for the first time in history," Xinhua reports. "UNICEF Executive Director Anthony Lake said in a statement released … on World Polio Day, which falls on Oct. 24, that 'fewer children than ever before suffer the debilitating effects of this cruel disease,'" the news service writes.

26 Oct 2012

Population Health Management discusses latest information on shingles and PHN

Shingles, a reactivation of the herpes zoster (chickenpox) virus affects nearly 1 in 3 Americans. About 1 million cases are diagnosed each year, with some patients suffering excruciating pain and itching due to post-herpetic neuralgia (PHN), a complication of the viral infection that can last for years despite treatment.

26 Oct 2012

Guidelines to help protect vulnerable populations from flu

While it is important to get vaccinated against the flu virus as early as possible, it is never too late to reap the benefits of this vaccine. According to The Centers for Disease Control and Prevention, the peak months for the spread of the flu virus are January and February and the season can last into mid-May.

26 Oct 2012

USPTO issues patent to Tobira’s cenicriviroc for treatment of HIV-1 infection

Tobira Therapeutics, Inc., developer of innovative antiretroviral therapies for HIV, today announced the United States Patent and Trademark Office has issued patent 8,183,273, claiming compositions of matter of a broad family of compounds with activity against chemokine receptors CCR5 and CCR2.

26 Oct 2012

Antiviral therapy cuts progression to cancer in hepatitis

Antiviral therapy may prevent the most common form of liver cancer developing among patients who have hepatitis C-related fibrosis or cirrhosis, report researchers.

25 Oct 2012

New method of testing for West Nile virus

While the United States has largely been spared the scourge of mosquito-borne diseases endemic to the developing world-including yellow fever, malaria and dengue fever-mosquito-related illnesses in the US are on the rise. One pathogen of increasing concern in the U.S. is an arbovirus known as West Nile.

24 Oct 2012

Rapid and point-of-care tests accurate, convenient for hepatitis C screening

Rapid and point-of-care screening tests for hepatitis C have a high accuracy and quick turnaround time, suggest results of a systematic review and meta-analysis.

24 Oct 2012

Flu protection: an interview with Dr Gillian SteelFisher of the Harvard School of Public Health in Boston, USA

In 2009, a new strain of influenza, or flu, virus emerged and spread rapidly to many countries around the world. It was declared a pandemic by the World Health Organization (WHO) in June 2009.

24 Oct 2012

Novel approach to assemble the 'connectome' via genetic barcoding

A team of neuroscientists has proposed a new and potentially revolutionary way of obtaining a neuronal connectivity map (the "connectome") of the whole brain of the mouse. The details are set forth in an essay published October 23 in the open-access journal PLOS Biology.

24 Oct 2012

Probiotic supplementation improves health-related quality of life during common cold

College students are notoriously sleep-deprived, live in close quarters and lead stress-filled lives, making them especially susceptible for contracting colds and upper-respiratory infections. For these reasons, a team lead by researchers at the University of Medicine and Dentistry of New Jersey-School of Health Related Professions (UMDNJ-SHRP) selected this population to study the effects of probiotic supplementation on health-related quality of life (HRQL) during the common cold.

24 Oct 2012

Vascular cell generation could be used to treat vascular disorders

A study in mice has shown that large numbers of vascular endothelial cells can be generated from human amniotic fluid-derived cells.

23 Oct 2012

KIF3A protein ferries HIV to the plasma membrane

A study in The Journal of Cell Biology identifies a motor protein that ferries HIV to the plasma membrane, helping the virus escape from macrophages.

23 Oct 2012

Genzyme, Alnylam partner to develop and commercialize RNAi therapeutics against ATTR

Alnylam Pharmaceuticals, Inc. and Genzyme, a Sanofi company, announced today that they have formed an exclusive alliance to develop and commercialize RNAi therapeutics targeting transthyretin (TTR) for the treatment of transthyretin-mediated amyloidosis (ATTR) in Japan and other Asia-Pacific countries.

23 Oct 2012

Abbott announces results from HUMIRA clinical studies on ulcerative colitis

Abbott (NYSE: ABT) today announced results from an analysis of three-year long-term data from an ongoing open-label extension of the HUMIRA (adalimumab) ULTRA 1 and ULTRA 2 studies.

23 Oct 2012

Researchers discover how HIV-infected people develop very powerful antibody responses

Wits researchers have played a pivotal role in an AIDS study published today in the journal, Nature Medicine, which describes how a unique change in the outer covering of the virus found in two HIV infected South African women enabled them to make potent antibodies which are able to kill up to 88% of HIV types from around the world.

23 Oct 2012

Interim results from CEL-SCI's Multikine Phase III study on head and neck cancer

CEL-SCI Corporation announced today that an interim review of the safety data from its open label, randomized, controlled, pivotal Phase III study of Multikine (Leukocyte Interleukin, Injection) investigational immunotherapy by an Independent Data Monitoring Committee (IDMC) raised no safety concerns.

23 Oct 2012

Sanofi presents overview of Phase II and III trials for quadrivalent influenza vaccine

Sanofi Pasteur, the vaccines division of Sanofi, presented today an overview of Phase II and Phase III clinical trials for its investigational quadrivalent influenza vaccine (QIV).

23 Oct 2012

Virus News and Research

Latest Virus News and Research

All health care workers should be vaccinated with annual flu vaccine to protect patients

RUB-medical researchers receive $2.3M Gates Foundation grant for HIV vaccine research

New HIV test for babies differs from conventional test, delivers diagnosis in less than an hour

UNICEF calls for 'finishing' global polio eradication; Rotary International warns of funding shortfall in India

Population Health Management discusses latest information on shingles and PHN

Guidelines to help protect vulnerable populations from flu

USPTO issues patent to Tobira’s cenicriviroc for treatment of HIV-1 infection

Antiviral therapy cuts progression to cancer in hepatitis

New method of testing for West Nile virus

Rapid and point-of-care tests accurate, convenient for hepatitis C screening

Flu protection: an interview with Dr Gillian SteelFisher of the Harvard School of Public Health in Boston, USA

Novel approach to assemble the 'connectome' via genetic barcoding

Probiotic supplementation improves health-related quality of life during common cold

Vascular cell generation could be used to treat vascular disorders

KIF3A protein ferries HIV to the plasma membrane

Genzyme, Alnylam partner to develop and commercialize RNAi therapeutics against ATTR

Abbott announces results from HUMIRA clinical studies on ulcerative colitis

Researchers discover how HIV-infected people develop very powerful antibody responses

Interim results from CEL-SCI's Multikine Phase III study on head and neck cancer

Sanofi presents overview of Phase II and III trials for quadrivalent influenza vaccine

A new way of characterising biomolecules eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in